Comparisons of human embryonic development in culture medium with and without antioxidant supplementatio

Not Applicable

Active, not recruiting

• Conditions: infertility; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12618001479291
• Lead Sponsor: Melbourne IVF

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-04
• Last Update Posted: 13 June 2022

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 1482

Inclusion Criteria

• Couples with female, male or unexplained infertility intending to undergo IVF or ICSI and where there are no medical contraindications to perform the treatment.
• The couple should have received verbal and written information/consent about the study.
• Blastocyst culture and fresh transfer on day 5 of a single embryo.
• Concomitant medications (eg; use of any oral antioxidants) will be recorded

Exclusion Criteria

• Previous participation in the study.
• Use of PGS where frozen embryo transfer is planned
• Testicular biopsy patients (TESA/TESE)
• Total freeze and no transfer possible.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy rate per randomised couple.<br>Clinical records will be used to gather this data for analysis[6 weeks post embryo transfer (foetal heart scan)]